Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2007
02/28/2007EP1757612A2 Tantal and Vanadium compounds and their use in Chemical Vapour deposition (CVD)
02/28/2007EP1756128A1 Phosphonium salts derivatives and their use as solubility controlling auxiliaries
02/28/2007EP1756127A1 Purification of n-(phosphonomethyl)glycine
02/28/2007EP1756126A1 Process for the alkylation of phosphorus-containing compounds
02/28/2007EP1756125A1 1,1,3,3,3-pentaamino-1lambda5,3lambda5-diphosphaz-2-enes, method for producing them and their use as agents for regulating or inhibiting enzymatic hydrolysis of urea
02/28/2007EP1756101A2 Androgen receptor modulators and method of treating disease using the same
02/28/2007EP1091928B1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
02/28/2007CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
02/28/2007CN1921210A Organic electrolytic solution and lithium battery using the same
02/28/2007CN1919853A Phosphor isoquinolinone, derivative, synthesis method and use thereof
02/28/2007CN1919852A Methods of purifying phosphitylated compounds
02/28/2007CN1302060C Novel flame retarding compounds
02/28/2007CN1302002C Hydroxylamine esters as polymerization initiators
02/28/2007CN1302001C Production of o-chlorobenzyl dimethyl phosphonate
02/28/2007CN1301998C New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives
02/28/2007CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use
02/28/2007CN1301986C Process for preparation of prostaglandins and analogues thereof
02/28/2007CN1301955C Process for the carbonylation of ethylenically unsaturated compouds
02/27/2007US7183446 Alcohol mixtures having 13 and 15 carbon atoms and the use thereof in the preparation of surface-active substances
02/27/2007US7183406 Method for the synthesis of DNA sequences
02/27/2007US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy
02/27/2007US7183268 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
02/27/2007US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
02/27/2007US7183059 Selecting desired synthetic precursors having defined stereochemical relationships, reacting precursors to obtain compound having specific stereochemistry, repeating selecting and reacting until desired library is obtained
02/22/2007WO2007021937A2 Unsaturated heterocyclic derivatives
02/22/2007WO2007021531A1 Absorbent composition containing molecules with a hindered amine and a metal sulfonate, phosphonate or carboxylate structure for acid gas scrubbing process
02/22/2007WO2007020620A1 Novel coupling agent and uses thereof
02/22/2007WO2007020473A1 Reactions of group 16 elements
02/22/2007WO2006107824A3 Control of n-(phosphonomethyl) iminodiacetic acid conversion in manufacture of glyphosate
02/22/2007WO2006076015A3 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
02/22/2007WO2006008653A9 Lipolytic enzyme uses thereof in the food industry
02/22/2007WO2006002185A8 Chemical compounds
02/22/2007US20070043234 Use of functionalized onium salts as a soluble support for organic synthesis
02/22/2007US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
02/22/2007US20070043207 6-Chlorobenzotriazol-1-yloxytriaminophosphonium salts (6-chiorobenzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate); highly reactive; peptide synthesis
02/22/2007US20070043206 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
02/22/2007US20070043051 Methods and compositions of novel triazine compounds
02/22/2007US20070043002 Aldolase-inhibiting aromatic compounds
02/22/2007US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties
02/22/2007US20070043000 Immunosuppresive effects of pteridine derivatives
02/22/2007US20070042999 Phosphate derivatives of pharmaceutical products
02/22/2007US20070042370 Fluorescent substrates for detecting organophosphatase enzyme activity
02/22/2007US20070042213 Tantalum and niobium compounds and their use for chemical vapour deposition (CVD)
02/22/2007CA2619098A1 Novel coupling agent and uses thereof
02/22/2007CA2618513A1 Unsaturated heterocyclic derivatives
02/22/2007CA2618385A1 Absorbent composition containing molecules with a hindered amine and a metal sulfonate, phosphonate or carboxylate structure for acid gas scrubbing process
02/21/2007EP1754710A2 2'-Fluoroncucleosides
02/21/2007EP1754709A1 Process for preparing vinylphosphates
02/21/2007EP1754597A2 Lithographic printing plate precursor and lithographic printing process
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753897A1 Method for electroplating bath chemistry control
02/21/2007EP1753772A1 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
02/21/2007EP1753762A1 Lewis acid mediated synthesis of cyclic esters
02/21/2007EP1753738A1 Pyrrole compounds as inibitors of erk protein kinase, synthesis thereof and intermediates thereto
02/21/2007EP1753712A1 Amino-propanol derivatives
02/21/2007EP1753707A1 Method of reducing a functional group in an oxidised form
02/21/2007EP1165570B9 Novel phosphorus-containing prodrugs
02/21/2007CN1918149A Novel chelating agents and highly luminescent and stable chelates and their use
02/21/2007CN1918126A Ionic uv-a sunscreens and compositions containing them
02/21/2007CN1916007A Preparing hexachlorocyclotriphosphazene, and purification method
02/21/2007CN1916006A New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
02/21/2007CN1916005A Method for preparing Phosphonomethyl iminodiacetic acid (PMIDA) through hydrolysis of imino diacetonitrile
02/21/2007CN1915997A New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
02/21/2007CN1301261C Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid and preparation method thereof
02/21/2007CN1301259C Preparation method for glyphosate from N-(phosphonomethyl)iminodiacetic acid
02/20/2007US7179946 Copper complexes and their use
02/20/2007US7179936 Process for recovering a crystalline product from solution
02/20/2007US7179928 Idebenone is reacted with Ph3PHX and Ph3P, where X is a halogen atom to form mitoquinone, reducing to form mitoquinol
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179906 Asymmetric benzoxanthene dyes
02/20/2007US7179905 Nucleic acid labeling compounds
02/20/2007CA2230770C Amidophosphinephosphinite compounds
02/20/2007CA2169561C Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acids
02/20/2007CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
02/15/2007WO2007018549A2 Allosterically catalyzed signal amplification in chemical and biological sensing
02/15/2007WO2007016982A1 A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
02/15/2007US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
02/15/2007US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof
02/15/2007US20070037981 Tertiary phosphines and their methods of preparation
02/15/2007US20070037964 Chemoselective ligation
02/15/2007US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV
02/15/2007US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
02/15/2007US20070037774 Novel cytarabine monophosphate prodrugs
02/15/2007US20070037764 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
02/15/2007US20070037763 Oligonucleotide compound and method for treating nidovirus infections
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system
02/15/2007US20070037234 Fluorogenic enzyme substrates and methods of preparation
02/15/2007US20070036894 Atomic layer deposition of tantalum-containing films using surface-activating agents and novel tantalum complexes
02/15/2007US20070036724 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
02/15/2007US20070034863 fac-tris[7,7-difluoro-7H-dibenzo[de,h]quinoline-C2,N]iridium(III) (Ir1)A: 7,7-Difluorodibenzo[de,h]quinoline; use in organic electronic devices such as electroluminescent elements, and to their use in displays based thereon
02/15/2007DE102006016258A1 Herstellung monomerer, oligomerer und polymerer Phosphon-säureester, Phosphonsäuren und Sulfonsäuren durch nucleophile aromatische Substitution Preparing monomeric, oligomeric and polymeric phosphonic acid esters, phosphonic and sulfonic acids by nucleophilic aromatic substitution
02/15/2007CA2606487A1 Generation of phosphorus oxychloride as by-product from phosphorus pentachloride and dmf and its use for chlorination reaction by converting into vilsmeier-haack reagent
02/14/2007EP1752463A1 Novel fluorinated alkylfluorophosphoric acid salt of onium and transition metal complex
02/14/2007EP1751239A1 Adhesion promoting compound
02/14/2007EP1751223A1 Flame retardants
02/14/2007EP1751170A1 Chiral phosphorus compounds
02/14/2007EP1751169A1 Bridged bi-aromatic catalysts, complexes, and method of using the same
02/14/2007EP1751128A1 Chromene-derivatives with anti-tubulin and vascular targeting activity
02/14/2007EP1750722A2 Novel lysophosphatidic acid receptor selective antagonists